Study Title
Phase 1 Imaging Study of 68Ga-R10602-101 in Hormone Receptor-Positive Breast Cancer
Study Details
Description:
A phase 1 imaging study of 68Ga-R10602 in hormone-receptor positive breast cancer.
Sponsor:
Radionetics Oncology
Contacts:
Yael Cohen-Arazir10602-101@radionetics.com
858-373-7793
Kristrun Stardalr10602-101@radionetics.com
949-887-9494
Government Study Link:
NCT06745804 - Click here to see study onClinicalTrials.gov
Drug Details
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468